175 related articles for article (PubMed ID: 36369745)
1. The IPTA Nashville consensus conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: II-consensus guidelines for prevention.
Green M; Squires JE; Chinnock RE; Comoli P; Danziger-Isakov L; Dulek DE; Esquivel CO; Höcker B; L'Huillier AG; Mazariegos GV; Visner GA; Bollard CM; Dipchand AI; Ferry JA; Gross TG; Hayashi R; Maecker-Kolhoff B; Marks S; Martinez OM; Metes DM; Michaels MG; Preiksaitis J; Smets F; Swerdlow SH; Trappe RU; Wilkinson JD; Allen U; Webber SA; Dharnidharka VR
Pediatr Transplant; 2024 Feb; 28(1):e14350. PubMed ID: 36369745
[TBL] [Abstract][Full Text] [Related]
2. The IPTA Nashville Consensus Conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: III - Consensus guidelines for Epstein-Barr virus load and other biomarker monitoring.
Preiksaitis J; Allen U; Bollard CM; Dharnidharka VR; Dulek DE; Green M; Martinez OM; Metes DM; Michaels MG; Smets F; Chinnock RE; Comoli P; Danziger-Isakov L; Dipchand AI; Esquivel CO; Ferry JA; Gross TG; Hayashi RJ; Höcker B; L'Huillier AG; Marks SD; Mazariegos GV; Squires J; Swerdlow SH; Trappe RU; Visner G; Webber SA; Wilkinson JD; Maecker-Kolhoff B
Pediatr Transplant; 2024 Feb; 28(1):e14471. PubMed ID: 37294621
[TBL] [Abstract][Full Text] [Related]
3. The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: I-Methodology for the development of consensus practice guidelines.
Wilkinson JD; Allen U; Green M; Dipchand AI; Dharnidharka VR; Esquivel CO; Maecker-Kolhoff B; Preiksaitis J; Swerdlow SH; Webber SA;
Pediatr Transplant; 2024 Feb; 28(1):e14333. PubMed ID: 36369733
[TBL] [Abstract][Full Text] [Related]
4. The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: IV-consensus guidelines for the management of post-transplant lymphoproliferative disorders in children and adolescents.
Allen UD; L'Huillier AG; Bollard CM; Gross TG; Hayashi RJ; Höcker B; Maecker-Kolhoff B; Marks SD; Mazariegos GV; Smets F; Trappe RU; Visner G; Chinnock RE; Comoli P; Danziger-Isakov L; Dulek DE; Dipchand AI; Ferry JA; Martinez OM; Metes DM; Michaels MG; Preiksaitis J; Squires JE; Swerdlow SH; Wilkinson JD; Dharnidharka VR; Green M; Webber SA; Esquivel CO
Pediatr Transplant; 2024 Aug; 28(5):e14781. PubMed ID: 38808744
[TBL] [Abstract][Full Text] [Related]
5. A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients: Guidance From the IPTA and ECIL Guidelines.
Yamada M; L'Huillier AG; Green M
J Pediatric Infect Dis Soc; 2024 Feb; 13(Supplement_1):S31-S38. PubMed ID: 38417085
[TBL] [Abstract][Full Text] [Related]
6. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey.
San-Juan R; Manuel O; Hirsch HH; Fernández-Ruiz M; López-Medrano F; Comoli P; Caillard S; Grossi P; Aguado JM; ;
Clin Microbiol Infect; 2015 Jun; 21(6):604.e1-9. PubMed ID: 25686696
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Allen UD; Preiksaitis JK;
Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
San-Juan R; Comoli P; Caillard S; Moulin B; Hirsch HH; Meylan P;
Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults.
Rubinstein J; Toner K; Gross T; Wistinghausen B
Best Pract Res Clin Haematol; 2023 Mar; 36(1):101446. PubMed ID: 36907642
[TBL] [Abstract][Full Text] [Related]
10. The Seville expert workshop for progress in posttransplant lymphoproliferative disorders.
Glotz D; Chapman JR; Dharnidharka VR; Hanto DW; Castro MC; Hirsch HH; Leblond V; Mehta AK; Moulin B; Pagliuca A; Pascual J; Rickinson AB; Russo FP; Trappe RU; Webster AC; Zuckermann AO; Gross TG
Transplantation; 2012 Oct; 94(8):784-93. PubMed ID: 22992767
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation.
Lindsay J; Yong MK; Greenwood M; Kong DCM; Chen SCA; Rawlinson W; Slavin M
Rev Med Virol; 2020 Jul; 30(4):e2108. PubMed ID: 32301566
[TBL] [Abstract][Full Text] [Related]
12. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.
Styczynski J; van der Velden W; Fox CP; Engelhard D; de la Camara R; Cordonnier C; Ljungman P;
Haematologica; 2016 Jul; 101(7):803-11. PubMed ID: 27365460
[TBL] [Abstract][Full Text] [Related]
13. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
Lim WH; Russ GR; Coates PT
Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines.
Parker A; Bowles K; Bradley JA; Emery V; Featherstone C; Gupte G; Marcus R; Parameshwar J; Ramsay A; Newstead C;
Br J Haematol; 2010 Jun; 149(5):675-92. PubMed ID: 20408847
[TBL] [Abstract][Full Text] [Related]
15. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders.
Afify ZAM; Taj MM; Orjuela-Grimm M; Srivatsa K; Miller TP; Edington HJ; Dalal M; Robles J; Ford JB; Ehrhardt MJ; Ureda TJ; Rubinstein JD; McCormack S; Rivers JM; Chisholm KM; Kavanaugh MK; Bukowinski AJ; Friehling ED; Ford MC; Reddy SN; Marks LJ; Smith CM; Mason CC
Cancer; 2023 Mar; 129(5):780-789. PubMed ID: 36571557
[TBL] [Abstract][Full Text] [Related]
16. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
Chiereghin A; Prete A; Belotti T; Gibertoni D; Piccirilli G; Gabrielli L; Pession A; Lazzarotto T
Transpl Infect Dis; 2016 Feb; 18(1):44-54. PubMed ID: 26574232
[TBL] [Abstract][Full Text] [Related]
17. Post-transplant lymphoproliferative disease in children, adolescents, and young adults.
Gross TG; Rubinstein JD
Hematol Oncol; 2023 Jun; 41 Suppl 1():48-56. PubMed ID: 37294957
[TBL] [Abstract][Full Text] [Related]
18. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.
Kogan-Liberman D; Burroughs M; Emre S; Moscona A; Shneider BL
J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):445-9. PubMed ID: 11698761
[TBL] [Abstract][Full Text] [Related]
19. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
Shapiro NL; Tang CG; Bhattacharyya N
Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
[TBL] [Abstract][Full Text] [Related]
20. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.
Green M; Reyes J; Webber S; Rowe D
Transpl Infect Dis; 2001 Jun; 3(2):97-103. PubMed ID: 11395975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
